News & Announcements
Latest accomplishments highlighting STSI in the media
Categories
Monthly Archives
- October, 2010
- September, 2010
- August, 2010
- July, 2010
- June, 2010
- May, 2010
- March, 2010
- February, 2010
- January, 2010
- November, 2009
- October, 2009
- August, 2009
- June, 2009
- February, 2009
- October, 2008
- September, 2008
- August, 2008
News & Announcements Feed
Dr. Eric Topol elected to California Healthcare Institute Board of Directors
August 02, 2010
California Healthcare Institute announced today that Eric J. Topol, M.D., director, Scripps Translational Science Institute; chief academic officer, Scripps Health; and vice chairman, West Wireless Health Institute; and Steve Krognes, senior vice president and chief financial officer at Genentech, a member of the Roche Group, have been elected to its board of directors. CHI is a non-profit public policy research organization, representing leading California academic institutions, biotechnology, medical device, diagnostics and pharmaceutical firms.
“Eric��(tm)s wealth of knowledge in translational medicine and the burgeoning area of wireless technology add a valuable dimension to our board,” said David Gollaher, Ph.D., CHI��(tm)s president and CEO, “and we are pleased to welcome back to our board Genentech, the oldest biotech company, with the addition of Steve, who orchestrated the largest biotech merger in history.”
Before joining Scripps, Topol served on the faculty of Case Western as a professor in genetics, chaired the Department of Cardiovascular Medicine at Cleveland Clinic for 15 years and raised its status to rank first by U.S. News and World Report for 11 consecutive years, and founded the Cleveland Clinic Lerner College of Medicine. His work in the genomics of heart attack has led to discovery of key genes recognized by the American Heart Association top 10 research advances in 2002 and 2004.
As a leader in clinical trials of novel therapeutics, he administered recombinant t-PA to the first patient in 1984, pioneered and led the clinical development of clopidogrel (Plavix), bivalirudin (Angiomax), and abciximab (ReoPro). He has more than 1,000 original peer reviewed publications, and has edited more than 30 books, including the Textbook of Interventional Cardiology (fifth edition), and the Textbook of Cardiovascular Medicine (third edition).
He has been a medical innovator in wireless medicine, including wireless ECG, vital signs, remote monitoring for heart failure, and as co-founder and Vice Chairman of the Gary & Mary West Wireless Health Institute.
Topol has been elected to the Institute of Medicine of the National Academy of Sciences, the American Association of Physicians and recognized by the Institute of Scientific Information (ISI) to be in the top 10 cited biomedical researchers in medicine in the past decade.
Steve Krognes is senior vice president and regional head, Finance and IT, and chief financial officer, Pharma North America at Genentech. In this role, he is responsible for Genentech��(tm)s Finance and Information Technology groups. He also serves on the Genentech Executive Committee. Krognes joined Roche in January 2004 as global head of Mergers and Acquisitions. In this role, he led Roche��(tm)s internal Mergers and Acquisitions group and was responsible for all Roche transactions worldwide. Prior to joining Roche, Krognes worked as a venture capitalist in Scandinavia, as a mergers and acquisitions investment banker with Goldman Sachs and Danske Bank, and as a management consultant with McKinsey & Co. Krognes holds a master��(tm)s in business administration from the Harvard Business School and a bachelor��(tm)s in economics from the Wharton School at the University of Pennsylvania. He is a second lieutenant in the Royal Norwegian Air Force.
About CHI
CHI represents more than 275 leading biotechnology, medical device, diagnostics, and pharmaceutical companies, and public and private academic biomedical research organizations. CHI��(tm)s mission is to advance responsible public policies that foster medical innovation and promote scientific discovery. CHI��(tm)s Web site is chi.org.
